CG Oncology (CGON) Payables: 2023-2025
Historic Payables for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $9.2 million.
- CG Oncology's Payables fell 18.85% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.6 million, marking a year-over-year increase of 10.31%. This contributed to the annual value of $6.5 million for FY2024, which is 101.02% up from last year.
- Per CG Oncology's latest filing, its Payables stood at $9.2 million for Q3 2025, which was up 29.02% from $7.1 million recorded in Q2 2025.
- In the past 5 years, CG Oncology's Payables ranged from a high of $11.3 million in Q3 2024 and a low of $3.2 million during Q4 2023.
- In the last 3 years, CG Oncology's Payables had a median value of $6.9 million in 2024 and averaged $7.0 million.
- In the last 5 years, CG Oncology's Payables spiked by 101.02% in 2024 and then dropped by 18.85% in 2025.
- Quarterly analysis of 3 years shows CG Oncology's Payables stood at $3.2 million in 2023, then skyrocketed by 101.02% to $6.5 million in 2024, then dropped by 18.85% to $9.2 million in 2025.
- Its Payables was $9.2 million in Q3 2025, compared to $7.1 million in Q2 2025 and $6.7 million in Q1 2025.